These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 782401

  • 1. Alternate-day prednisone therapy in recipients of renal allografts. Risk and benefits.
    Diethelm AG, Sterling WA, Hartley MW, Morgan JM.
    Arch Surg; 1976 Aug; 111(8):867-70. PubMed ID: 782401
    [Abstract] [Full Text] [Related]

  • 2. Comparison of alternate day steroids and daily steroids in renal transplant recipients.
    Davisson NA, Westervelt FB, Bolton WK.
    Proc Clin Dial Transplant Forum; 1980 Aug; 10():150-4. PubMed ID: 7050977
    [Abstract] [Full Text] [Related]

  • 3. Renal transplantation in young children.
    Fine RN, Korsch BM, Brennan LP, Edelbrock HH, Stiles QR, Riddell HI, Weitzman JJ, Mickelson JC, Tucker BL, Grushkin CM.
    Am J Surg; 1973 May; 125(5):559-69. PubMed ID: 4572971
    [No Abstract] [Full Text] [Related]

  • 4. Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.
    Burleson RL, Scruggs BF, Brennan A.
    Clin Nephrol; 1978 Sep; 10(3):87-9. PubMed ID: 359210
    [Abstract] [Full Text] [Related]

  • 5. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC, Rohrer RM, Kaplan MM.
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [Abstract] [Full Text] [Related]

  • 6. [Cortisone cataract after renal transplantation].
    Mahlich J, Thiel G, Dobrivojevic D, Brunner F, Enderlin F.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):860-5. PubMed ID: 4555724
    [No Abstract] [Full Text] [Related]

  • 7. Growth after conversion to alternate-day corticosteroids in children with renal transplants: a single-center study.
    Kaiser BA, Polinsky MS, Palmer JA, Dunn S, Mochon M, Flynn JT, Baluarte HJ.
    Pediatr Nephrol; 1994 Jun 02; 8(3):320-5. PubMed ID: 7917858
    [Abstract] [Full Text] [Related]

  • 8. Posterior subcapsular cataracts: posttransplantation in children.
    Fine RN, Offner G, Wilson WA, Mickey MR, Pennisi AF, Malekzadeh MH.
    Ann Surg; 1975 Nov 02; 182(5):585-9. PubMed ID: 1103758
    [Abstract] [Full Text] [Related]

  • 9. Alternate-day steroids in children after renal transplantation.
    Potter DE, Holliday MA, Wilson CJ, Salvatierra O, Belzer FO.
    Transplant Proc; 1975 Mar 02; 7(1):79-82. PubMed ID: 47201
    [No Abstract] [Full Text] [Related]

  • 10. Alternate-day single-dose prednisone therapy: a method of reducing steroid toxicity.
    Bell MJ, Martin LW, Gonzales LL, McEnery PT, West CD.
    J Pediatr Surg; 1972 Apr 02; 7(2):223-9. PubMed ID: 4554025
    [No Abstract] [Full Text] [Related]

  • 11. Reduction of toxicity of corticosteroid therapy after renal transplantation.
    Siegel RR, Luke RG, Hellebusch AA.
    Am J Med; 1972 Aug 02; 53(2):159-69. PubMed ID: 4559148
    [No Abstract] [Full Text] [Related]

  • 12. Steroid-related complications in the cyclosporine era.
    Fryer JP, Granger DK, Leventhal JR, Gillingham K, Najarian JS, Matas AJ.
    Clin Transplant; 1994 Jun 02; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [Abstract] [Full Text] [Related]

  • 13. Growth and development of children with renal transplants. Use of alternate-day steroid therapy.
    McEnery PT, Gonzalez LL, Martin LW, West CD.
    J Pediatr; 1973 Nov 02; 83(5):806-14. PubMed ID: 4582575
    [No Abstract] [Full Text] [Related]

  • 14. Effect of alternate-day steroids on renal transplant function. A controlled study.
    McDonald FD, Horensten ML, Mayor GB, Turcotte JG, Selezinka W, Schork MA.
    Nephron; 1976 Nov 02; 17(6):415-29. PubMed ID: 796739
    [Abstract] [Full Text] [Related]

  • 15. Alternate day prednisone treatment may increase kidney transplant rejection.
    Leb DE.
    Proc Clin Dial Transplant Forum; 1979 Nov 02; 9():136-9. PubMed ID: 399501
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy.
    Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG.
    Clin Nephrol; 1976 Mar 02; 5(3):123-7. PubMed ID: 770034
    [Abstract] [Full Text] [Related]

  • 17. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Mar 02; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 18. Ocular complications in renal transplant recipients.
    Pavlin CR, deVeber GA, Cook GT, Chisholm LD.
    Can Med Assoc J; 1977 Aug 20; 117(4):360-2. PubMed ID: 329970
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L, Ding T, Wang XX, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681
    [Abstract] [Full Text] [Related]

  • 20. Aseptic necrosis after renal transplantation in children.
    Uittenbogaart CH, Isaacson AS, Stanley P, Pennisi AJ, Malekzadeh MH, Ettenger RB, Fine RN.
    Am J Dis Child; 1978 Aug 31; 132(8):765-7. PubMed ID: 356587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.